MIST Milestone Pharmaceuticals Inc

Price (delayed)

$5.98

Market cap

$178.48M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.36

Enterprise value

$107.51M

Highlights
The EPS has soared by 52% YoY and by 20% QoQ
The net income rose by 25% YoY and by 8% QoQ
MIST's debt has soared by 151% YoY but it is down by 6% QoQ
The company's equity rose by 32% YoY but it fell by 8% QoQ

Key stats

What are the main financial stats of MIST
Market
Shares outstanding
29.85M
Market cap
$178.48M
Enterprise value
$107.51M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.35
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$46.16M
EBITDA
-$46.06M
Free cash flow
-$45.12M
Per share
EPS
-$1.36
Free cash flow per share
-$1.09
Book value per share
$4.42
Revenue per share
$0
TBVPS
$3.36
Balance sheet
Total assets
$138.44M
Total liabilities
$6.45M
Debt
$887,000
Equity
$131.99M
Working capital
$131.43M
Liquidity
Debt to equity
0.01
Current ratio
23.6
Quick ratio
22.38
Net debt/EBITDA
1.54
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-37.6%
Return on equity
-39.7%
Return on invested capital
-81.7%
Return on capital employed
-34.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MIST stock price

How has the Milestone Pharmaceuticals stock price performed over time
Intraday
5.47%
1 week
10.95%
1 month
7.75%
1 year
41.04%
YTD
-10.75%
QTD
3.28%

Financial performance

How have Milestone Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$46.55M
Net income
-$46.14M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 27% YoY and by 8% from the previous quarter
The net income rose by 25% YoY and by 8% QoQ

Growth

What is Milestone Pharmaceuticals's growth rate over time

Valuation

What is Milestone Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.35
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 52% YoY and by 20% QoQ
The company's equity rose by 32% YoY but it fell by 8% QoQ
The P/B is 3.6% lower than the last 4 quarters average of 1.4

Efficiency

How efficient is Milestone Pharmaceuticals business performance
The ROIC has soared by 81% YoY and by 34% QoQ
MIST's ROA is up by 20% YoY and by 14% QoQ
Milestone Pharmaceuticals's return on equity has increased by 20% YoY and by 14% QoQ

Dividends

What is MIST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MIST.

Financial health

How did Milestone Pharmaceuticals financials performed over time
The total assets is up by 32% year-on-year but it has declined by 8% since the previous quarter
The current ratio has grown by 21% YoY but it has contracted by 2.2% from the previous quarter
MIST's debt is 99% lower than its equity
MIST's debt has soared by 151% YoY but it is down by 6% QoQ
The company's equity rose by 32% YoY but it fell by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.